[Purification of biomolecules by the method of the expanded bed adsorption chromatography. III. Method optimization. Aplications].

This review introduces the principles of the expanded bed adsorption (EBA) and serves as a practical guide to the use STREAMLINE adsorbent and columns available on the market. Critical operational parameters will be discussed as well as the principles for the method design and optimization that will ensure maximum operation of this unique unit. The review is illustrated with the examples of different types of biological molecules which have been purified when using the expanded bed adsorption.

[Biomoleculs purification by the method of the expanded bed adsorption chromatography. II. Design of the experiment].

This review introduces the principles of the Expanded Bed Adsorption (EBA) and serves as a practical guide to the use of STREAMLINE adsorbent and columns available on the market. Critical operating parameters will be discussed as well as principles for the method design and optimization which will ensure maximum exploitation of this unique operation stage. The review is illustrated with examples of different types of biological molecules which have been purified using Expanded Bed Adsorption.

[Purification of biomolecules by the method of adsorptional chromatography in the expanded bed. I. Principles of the method].

Principles the Expanded Bed Adsorption (EBA) have been described in the survey. The paper also deals with critical operation parameters, principles of the method design and optimization, which will guarantee maximum operation of this unique operation stage. All these problems have been discussed.

[Enterosorption and therapeutic plasmapheresis in the intensive therapy of patients with acute leukemia and of persons who were victims of the accident at the Chernobyl Atomic Electric Power Station].

The paper reports on the preliminary experience of treatment of those patients having been the victims to the reactor accident at the Chernobyl NPP as well as of those with acute and chronic leukoses, having received courses of modern cytostatic therapy. The patients were exposed to therapeutic plasmapheresis and enterosorption as part of a complex conventional treatment programme. The conclusion the authors have come to is as follows: enterosorption strikingly reduces manifestations of "cytostatic disease"; the use of plasmapheresis in those persons having been previously exposed to small dose chronic radiation, makes for improvement of clinical and laboratory values but further studies are warranted to determine indications for therapeutic plasmapheresis.